Full Text
Hta Outcomes for Orphan Drugs in Oncology- Comparison of France, Germany and England

Abstract

Authors

S Jarosławski M Toumi D Korchagina P Auquier C Dussart

Back to Volume 21, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×